D-0752-2022 Class III Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-0752-2022 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Apr 1, 2022 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated Apr 3, 2023). Affected quantity: 19,222 Bottles (100-count).

Recall details

Product Type
Drugs
Report Date
Apr 13, 2022
Initiation Date
Apr 1, 2022
Termination Date
Apr 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,222 Bottles (100-count)

Product description

Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06

Reason for recall

Subpotent

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot # 21 P0322, Exp. 01/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0752-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0752-2022. Report a data issue: hello@regdatalab.com.